These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9543287)
21. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Chang LF; Horvath J; Peyton W; Ling SS Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330 [TBL] [Abstract][Full Text] [Related]
22. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy. Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162 [TBL] [Abstract][Full Text] [Related]
23. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma. Ofiara L; Roman T; Schwartzman K; Levy RD Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957 [TBL] [Abstract][Full Text] [Related]
24. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780 [TBL] [Abstract][Full Text] [Related]
25. High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. Seagren SL; Harrell JH; Horn RA Chest; 1985 Dec; 88(6):810-4. PubMed ID: 2415306 [TBL] [Abstract][Full Text] [Related]
26. [Reappraisal of the role of endobronchial brachytherapy in the management of lung cancer: ten years' experience at the centre Antoine-Lacassagne]. Magné N; Porsin B; Marcy PY; Benezery K; Poudenx M; Vallino P; Otto J; Marcié S; Lagrange JL Cancer Radiother; 2003 Jun; 7(3):160-5. PubMed ID: 12834770 [TBL] [Abstract][Full Text] [Related]
27. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Langendijk JA; Tjwa MK; de Jong JM; ten Velde GP; Wouters EF Radiother Oncol; 1998 Nov; 49(2):175-83. PubMed ID: 10052884 [TBL] [Abstract][Full Text] [Related]
28. [Endobronchial brachytherapy: technique and indications]. Hennequin C; Bleichner O; Trédaniel J; Maylin C Cancer Radiother; 2003 Feb; 7(1):33-41. PubMed ID: 12648715 [TBL] [Abstract][Full Text] [Related]
29. [High dose rate brachytherapy: a potentially curative treatment for small invasive T1N0 endobronchial carcinoma and carcinoma in situ]. Lorchel F; Spaeth D; Scheid P; Aletti P; Thariat J; Peiffert D Rev Mal Respir; 2003 Sep; 20(4):515-20. PubMed ID: 14528153 [TBL] [Abstract][Full Text] [Related]
30. High dose-rate endobronchial radiotherapy for proximal airway obstruction due to lung cancer: 8-year experience of a referral center. Manali ED; Stathopoulos GT; Gildea TR; Fleming P; Thornton J; Xu M; Papiris SA; Mehta AC; Mughal MM Cancer Biother Radiopharm; 2010 Apr; 25(2):207-13. PubMed ID: 20423234 [TBL] [Abstract][Full Text] [Related]
31. High-dose rate brachytherapy of bronchial cancer: treatment optimization using three schemes of therapy. Muto P; Ravo V; Panelli G; Liguori G; Fraioli G Oncologist; 2000; 5(3):209-14. PubMed ID: 10884499 [TBL] [Abstract][Full Text] [Related]
32. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560 [TBL] [Abstract][Full Text] [Related]
33. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions. Spásová I; Petera J Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295 [TBL] [Abstract][Full Text] [Related]
34. Endoluminal high dose rate brachytherapy in the treatment of primary and recurrent bronchogenic tree malignancies. Fortunato M; Feijó S; Almeida T; Mendonça V; Aguiar M; Jorge M; Monteiro Grillo I Rev Port Pneumol; 2009; 15(2):151-64. PubMed ID: 19280066 [TBL] [Abstract][Full Text] [Related]
35. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Freitag L; Ernst A; Thomas M; Prenzel R; Wahlers B; Macha HN Thorax; 2004 Sep; 59(9):790-3. PubMed ID: 15333857 [TBL] [Abstract][Full Text] [Related]
36. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience. Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031 [TBL] [Abstract][Full Text] [Related]
37. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Pérol M; Caliandro R; Pommier P; Malet C; Montbarbon X; Carrie C; Ardiet JM Chest; 1997 May; 111(5):1417-23. PubMed ID: 9149603 [TBL] [Abstract][Full Text] [Related]
38. Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma. Tomberlin JK; Halperin EC; Kusin P; Leopold K; Bentel G; George S; Powers M; Wolfe W J Surg Oncol; 1992 Apr; 49(4):213-9. PubMed ID: 1556864 [TBL] [Abstract][Full Text] [Related]
39. Physiological effect of endobronchial radiotherapy in patients with major airway occlusion by carcinoma. Goldman JM; Bulman AS; Rathmell AJ; Carey BM; Muers MF; Joslin CA Thorax; 1993 Feb; 48(2):110-4. PubMed ID: 8388128 [TBL] [Abstract][Full Text] [Related]
40. Endobronchial brachytherapy with curative intent: the impact of reference points setting according to the bronchial diameter. Nomoto Y; Ii N; Murashima S; Yamashita Y; Ochiai S; Takada A; Toyomasu Y; Kawamura T; Sakuma H J Radiat Res; 2017 Nov; 58(6):849-853. PubMed ID: 29106573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]